These bacteria are among the most prevalent microorganisms causing recurrent respiratory tract infections in patients with primary antibody deficiencies (PAD).6 Approximately 8–10% of patients with the most common PAD, combined variable immunodeficiency (CVID), have homo‐ or heterozygous mutations in TACI. The gene discussed is TNFRSF13B; the disease is peripheral arterial disease.